Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syros Pharmaceuticals, Inc.

0.0250
-0.0001-0.40%
Volume:49.71K
Turnover:1.25K
Market Cap:670.81K
PE:-0.01
High:0.0273
Open:0.0245
Low:0.0245
Close:0.0251
Loading ...
Sep 15, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 02, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 13, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 06, 2022

Major Issues Report

8-K - Current report
Jul 06, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Jul 05, 2022

Major Issues Report

8-K - Current report
Jul 05, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 07, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals